These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 11730567

  • 21. Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.
    Koreen AR, Lieberman J, Alvir J, Mayerhoff D, Loebel A, Chakos M, Amin F, Cooper T.
    Arch Gen Psychiatry; 1994 Feb; 51(2):132-8. PubMed ID: 7905259
    [Abstract] [Full Text] [Related]

  • 22. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement.
    Nibuya M, Kanba S, Sekiya U, Suzuki E, Matsuo Y, Kinoshita N, Shintani F, Yagi G, Asai M.
    Biol Psychiatry; 1995 Jul 01; 38(1):50-6. PubMed ID: 7548472
    [Abstract] [Full Text] [Related]

  • 23. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).
    Ohnuma T, Sakai Y, Maeshima H, Hatano T, Hanzawa R, Abe S, Kida S, Shibata N, Suzuki T, Arai H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1905-12. PubMed ID: 18835577
    [Abstract] [Full Text] [Related]

  • 24. Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia.
    Müller MJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1095-100. PubMed ID: 17493732
    [Abstract] [Full Text] [Related]

  • 25. Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine.
    Sumiyoshi T, Hasegawa M, Jayathilake K, Meltzer HY.
    Psychiatry Res; 1997 Mar 24; 69(2-3):113-21. PubMed ID: 9109179
    [Abstract] [Full Text] [Related]

  • 26. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia.
    Petronijević ND, Radonjić NV, Ivković MD, Marinković D, Piperski VD, Duricić BM, Paunović VR.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1921-6. PubMed ID: 18824063
    [Abstract] [Full Text] [Related]

  • 27. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T, Liraud F, Verdoux H.
    Encephale; 2003 Dec 12; 29(5):430-7. PubMed ID: 14615692
    [Abstract] [Full Text] [Related]

  • 28. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M, Loza B.
    Psychiatr Pol; 2004 Dec 12; 38(5):795-808. PubMed ID: 15523927
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Measurement of plasma homovanillic acid concentrations in schizophrenic patients.
    Kaminski R, Powchick P, Warne PA, Goldstein M, McQueeney RT, Davidson M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Dec 12; 14(3):271-87. PubMed ID: 2193315
    [Abstract] [Full Text] [Related]

  • 33. Plasma homovanillic acid in adolescents with bulimia nervosa.
    Castro-Fornieles J, Deulofeu R, Martínez-Mallen E, Baeza I, Fernández L, Lázaro L, Toro J, Vila M, Bernardo M.
    Psychiatry Res; 2009 Dec 30; 170(2-3):241-4. PubMed ID: 19836840
    [Abstract] [Full Text] [Related]

  • 34. Differential effects of mental stress on plasma homovanillic acid in schizophrenia and normal controls.
    Sumiyoshi T, Saitoh O, Yotsutsuji T, Itoh H, Kurokawa K, Kurachi M.
    Neuropsychopharmacology; 1999 Apr 30; 20(4):365-9. PubMed ID: 10088137
    [Abstract] [Full Text] [Related]

  • 35. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.
    Reynolds GP, Yao Z, Zhang X, Sun J, Zhang Z.
    Eur Neuropsychopharmacol; 2005 Mar 30; 15(2):143-51. PubMed ID: 15695058
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Heterogeneity of response to antipsychotics from multiple disorders in the schizophrenia spectrum.
    Garver DL, Holcomb JA, Christensen JD.
    J Clin Psychiatry; 2000 Dec 30; 61(12):964-72; quiz 973. PubMed ID: 11206608
    [Abstract] [Full Text] [Related]

  • 38. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S, Gönül AS, Taneli F, Akdeniz F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul 30; 28(4):709-13. PubMed ID: 15276697
    [Abstract] [Full Text] [Related]

  • 39. Plasma homovanillic acid and treatment response in a large group of schizophrenic patients.
    Chang WH, Hwu HG, Chen TY, Lin SK, Lung FW, Chen H, Lin WL, Hu WH, Lin HN, Chien CP.
    Schizophr Res; 1993 Oct 30; 10(3):259-65. PubMed ID: 8260444
    [Abstract] [Full Text] [Related]

  • 40. Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
    Yoshimura R, Shinkai K, Ueda N, Nakamura J.
    Pharmacopsychiatry; 2007 Jan 30; 40(1):9-13. PubMed ID: 17327954
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.